Calliditas Therapeutics AB (publ) (CALT) Institutional Ownership → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free CALT Stock Alerts $39.49 -1.92 (-4.64%) (As of 06/7/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Calliditas Therapeutics AB (publ) (NASDAQ:CALT)CurrentInstitutional OwnershipPercentage2.83%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$25.23KNumber ofInstitutional Sellers(last 12 months)0 Get CALT Insider Trade Alerts Want to know when executives and insiders are buying or selling Calliditas Therapeutics AB (publ) stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CALT Institutional Buying and Selling by Quarter Ad HedgeyeNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY Calliditas Therapeutics AB (publ) Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024 Optiver Holding B.V.980$25K0.0%N/A0.003% 5/15/2023 Ironwood Investment Management LLC27,795$666K0.4%+5.6%0.093% 5/11/2023 Optiver Holding B.V.5,029$120K0.0%-54.9%0.017% 2/10/2023 Optiver Holding B.V.11,141$195K0.0%-11.8%0.037% 2/9/2023 HBK Sorce Advisory LLC90,000$104K0.0%+100.0%0.302% 1/31/2023 Ironwood Investment Management LLC26,309$447K0.3%-8.5%0.088% Get the Latest News and Ratings for CALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022 Optiver Holding B.V.12,625$191K0.0%+1,304.3%0.043% 11/14/2022 HBK Sorce Advisory LLC45,000$50K0.0%N/A0.152% 5/10/2022 Ironwood Investment Management LLC28,762$551K0.3%+5.5%0.110% 2/10/2022 Ironwood Investment Management LLC27,267$675K0.3%-2.0%0.104% 11/12/2021 Ironwood Investment Management LLC27,836$602K0.3%+75.2%0.106% 8/27/2021 Endurant Capital Management LP144,393$4.25M1.2%+1.5%0.552% 8/12/2021 Advisory Services Network LLC3,369$99K0.0%N/A0.013% 8/11/2021 Deutsche Bank AG71,531$2.11M0.0%+1.8%0.286% 7/31/2021NEXT Financial Group Inc4,458$131K0.0%N/A0.018% 5/19/2021 Hillhouse Capital Advisors LTD.944,716$26.10M0.3%-9.8%3.783% 5/18/2021 Millennium Management LLC15,570$430K0.0%-24.0%0.062% 5/18/2021 Tudor Investment Corp Et Al13,782$380K0.0%N/A0.055% 5/18/2021 Citadel Advisors LLC9,571$264K0.0%N/A0.038% 5/17/2021 Endurant Capital Management LP142,323$3.92M1.0%N/A0.570% 2/17/2021 Jane Street Group LLC7,557$256K0.0%-26.5%0.032% 2/13/2021 Hillhouse Capital Advisors LTD.1,047,687$35.61M0.3%+199.3%4.371% 12/9/2020 Pentwater Capital Management LP61,084$1.47M0.0%-7.4%0.255% 11/17/2020 Jane Street Group LLC10,278$244K0.0%+13.8%0.043% 11/17/2020 Logos Global Management LP550,000$13.20M1.7%+83.3%2.295% 11/16/2020 Point72 Asset Management L.P.257,892$6.19M0.0%-42.7%1.076% 11/6/2020 BlackRock Inc.1,191$29K0.0%N/A0.005% (Data available from 1/1/2016 forward) CALT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CALT shares? During the previous two years, the following institutional investors and hedge funds held shares of Calliditas Therapeutics AB (publ) shares: Ironwood Investment Management LLC ($666K), and HBK Sorce Advisory LLC ($104K), Optiver Holding B.V. ($25K).Learn more on CALT's institutional investors. What percentage of Calliditas Therapeutics AB (publ) stock is owned by institutional investors? 2.83% of Calliditas Therapeutics AB (publ) stock is owned by institutional investors. Learn more on CALT's institutional investor holdings. Which institutional investors have been buying Calliditas Therapeutics AB (publ) stock? The following institutional investors have purchased Calliditas Therapeutics AB (publ) stock in the last 24 months: HBK Sorce Advisory LLC ($90K), Optiver Holding B.V. ($12.71K), and Ironwood Investment Management LLC ($1.49K). How much institutional buying is happening at Calliditas Therapeutics AB (publ)? Institutional investors have bought a total of 104,192 shares in the last 24 months. This purchase volume represents approximately $1.69M in transactions. Which Calliditas Therapeutics AB (publ) major shareholders have been selling company stock? The following institutional investors have sold Calliditas Therapeutics AB (publ) stock in the last 24 months: Optiver Holding B.V. ($7.60K), and Ironwood Investment Management LLC ($2.43K). How much institutional selling is happening at Calliditas Therapeutics AB (publ)? Institutional investors have sold a total of 10,029 shares in the last 24 months. This volume of shares sold represents approximately $213.09K in transactions. Related Companies: Travere Therapeutics Major Shareholders Enanta Pharmaceuticals Major Shareholders Omeros Major Shareholders NGM Biopharmaceuticals Major Shareholders Nuvalent Major Shareholders Alpine Immune Sciences Major Shareholders Alkermes Major Shareholders Crinetics Pharmaceuticals Major Shareholders Perrigo Major Shareholders Axsome Therapeutics Major Shareholders This page (NASDAQ:CALT) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calliditas Therapeutics AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Calliditas Therapeutics AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.